Joby Aviation, GeneDx Holdings, and DraftKings were three of the four stocks that Wood's ETF company bought on Monday. Joby Aviation turned heads late on Monday, after announcing a partnership with th
GAITHERSBURG, Md.--(BUSINESS WIRE)--Announcing GeneDx's new genetic testing program with Zevra Therapeutics to support patients with suspected Niemann–Pick disease type C (NPC).
The consensus price target hints at a 77.8% upside potential for GENEDX HOLDINGS (WGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced scientific contributions to be pr
Stock News Oil tops $100 as supply risks mount: Brent surged intraday to $119 and WTI neared $119 amid a near-halt through the Strait of Hormuz and strikes on e
Intech Investment Management LLC cut its holdings in GeneDx Holdings Corp. (NASDAQ: WGS) by 41.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) CEO Katherine Stueland sold 25,459 shares of the business's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average pr
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) Director Keith Meister purchased 29,495 shares of the firm's stock in a transaction dated Tuesday, March 3rd. The shares were bought at an average
Stock News Oil jumps on Hormuz shutdown fears: United States Oil Fund (USO) tracked crude's surge past $80 as tanker traffic in the Strait of Hormuz stalled and
COO Bryan Dechairo sold 5,961 directly-held shares for a transaction value of approximately $510,900 on Feb. 4, 2026. The sale represented 100% of Mr.
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced that company management will participate in the upcoming TD Cowen and Barclays healthcare investor conferences.
GeneDx Holdings Corp (NASDAQ: WGS) reported better-than-expected fourth-quarter financial results on Monday.
GeneDx (WGS) is upgraded to 'Buy' as valuation resets and operational improvements support a more realistic growth outlook. Per my DCF model, WGS now targets 25% CAGR and 10% free cash flow margins, w
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE